查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球心电图监测仪市场
市场调查报告书
商品编码
1146428

2022-2029 年全球心电图监测仪市场

Global Cardiac Holter Monitor Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

心臟动态监测仪的市场规模预计到 2021 年将达到 4.11 亿美元，到 2029 年将达到 5.77 亿美元，在预测期内（2022-2029 年）以 5.4% 的复合年增长率增长。

动态心电监护仪是一种持续监测设备，可以对患者的心臟进行短期（24 到 48 小时）监测，有些监测仪的使用期限长达 14 天。 ECG Holter 监测器是第一个动态心臟监测器，用于在没有静息 ECG 监测器的情况下进行长期心臟监测。 Holter 监视器因其适用于门诊实践而在世界范围内被广泛接受。

市场动态

由于对长期患者监测的需求不断增长和门诊费用的降低，心臟动态心电图监测仪的全球市场正在增长，而心血管疾病患病率的上升推动了近年来心臟动态心电图监测仪的增长。

心血管疾病患病率上升推动市场增长

血管成形术被推荐用于治疗外周血管疾病。在此过程中，心臟导管用于探查受影响的动脉并使动脉再通以消除动脉壁的阻塞。根据美国心臟协会的一项研究，到 2020 年，将有 9210 万美国人患有某种形式的 CVD，这使得 CVD 成为美国的头号死因，而不是癌症和其他慢性病。

在世界发展中国家，老年人口的增加是主要问题之一。此外，预计在未来一段时间内，老年人慢性疾病的患病率将会增加，例如主动脉疾病、静脉血栓栓塞症和外周动脉疾病。根据美国疾病控制和预防中心的数据，到 2020 年，全球 55 至 65 岁人口中将有超过 19.1% 的人患有外周血管疾病，据推测，大约 27% 的男性和超过 21% 的女性会受到影响。亚太地区是老年人口最集中的地区，而且这一数字正以历史最高水平增长。

预计严格的政府法规会阻碍市场增长

对于现有企业，我们预计技术增强型手持设备的价格压力会越来越大，这些设备比标准 ECG 更具成本效益。此外，由于现行政府法规导致的较低报销率预计会影响产品成本。例如，2021 年 11 月，当 2022 年 Medicare 医师费用表最终规则发布时，全面的外部 ECG 监测再次从定价讨论中删除。这可能会降低小工具的医疗保险费率，这将对其采用产生负面影响。

COVID-19 影响分析

由于治疗、诊断和手术等服务被暂停以阻止 COVID-19 疾病的传播，预计 COVID-19 流行病将对全球导管行业的增长产生短期负面影响。预测.据国家医学图书馆称，约旦实施了与 COVID-19 相关的严格封锁。心血管治疗量在严格的封锁期间急剧下降，并在部分放鬆封锁后逐渐增加。然而，随着政府和医疗机构继续加强对 COVID-19 患者的护理，导管将在医院中更频繁地使用。

行业分析

全球心臟动态心电图监测仪市场基于各种行业因素，如波特五力、监管分析、供应炼和定价分析、报销政策、技术进步、PEST 分析等。

细分市场分析

无线动态心电监护仪细分市场有望在全球心臟动态心电监护仪市场占据最大市场份额

无线动态心电监护仪主要用于监测患有心悸、室性心动过速和房颤的患者。这得益于它在大中型医院广泛用于心血管疾病患者的诊断。

扩展型动态心电技术（贴片）是一种无需电线的长效动态心电设备。使用 2 盘技术，您需要使用蓝牙技术将数据同步到远程设备。根据 2018 年 3 月 19 日在奥兰多举行的美国心脏病学会第 67 届年度科学会议上公布的为期一年的数据，对于那些心房颤动 (AFib) 风险增加的人，发现佩戴记录心臟模式的自粘胸贴与依赖常规护理相比，可以更好地检测医疗状况并促进更及时的治疗。

据研究人员称，这项名为预防中风的移动健康筛查 (mSToPS) 试验的研究是第一个完全数位化、全国性、直接面向参与者、无地点的临床研究项目。患者同意并通过基于网络的平台註册，以便在家中使用 iRhythm Zio 贴片进行主动监测。该贴片可连续记录心电图（检测心房颤动的金标准），大小与创可贴差不多。此外，心电图记录贴片对于检测心房颤动必不可少，製造商正在推出创新、小型化和更方便的产品。例如，iRhythm 的 Zio XT 贴片将动态心电图监测器整合到一个小巧的计步器大小的粘性设备中。只需将其贴在胸壁上，即可连续监测 14 天的心率。

区域分析

北美在全球心臟动态心电监护仪市场中占据最大的市场份额。

北美将在 2021 年主导全球心臟动态心电监护仪市场。这一巨大的收入份额主要是由于心血管疾病患病率上升等原因所致。心臟相关疾病和相关生活方式疾病的增加正在推动北美心臟监测市场，技术开发、产品发布和製造商之间的合作协议的增加推动了新产品开发的增长，而不断增加的产品组合反过来又增加了市场机会。预计市场还将受到各种市场参与者和美国政府在开发和商业化各种易于使用的设备方面增加投资的推动。例如，2018 年 5 月，Preventis Solutions 推出了 BodyGuardian Mini，这是一种用于心臟监测的可重复使用、长期和最小的 Holter 技术。这项新技术包括一个超紧凑的心臟监测器，可以测量心电图长达 14 天，并可以将数据以易于阅读的报告形式传输给您的医生。因此，此类满足医生和患者需求的技术先进产品的推出有望在未来几年推动市场增长。

竞争格局

心臟动态心电监护仪市场是一个竞争激烈的市场，一些业内最大的参与者进入了这个市场。为全球市场增长做出贡献的主要心臟动态心电监护仪参与者包括 Medtronic Plc, GE Healthcare, Spacelabs Healthcare, FUKUDA DENSHI CO.LTD., Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., Schiller AG, BTL, Koninklijke Philips N.V., ScottCare Corporation.。

全球心臟动态心电图监测市场——值得关注的主要参与者

美敦力公司

概述美敦力公司是一家製造和销售医疗器械的美国公司，总部位于美国明尼阿波利斯。它在大约 140 个国家开展业务，拥有 90,000 名员工。

产品组合 Reveal LINQ 系统包括一个佩戴在皮肤下的小型可插入监视器和一个 MyCareLink 患者监视器。

这份报告提供了大约 45+ 市场数据表、40+ 图表和 180 页关于全球心臟动态心电监护仪市场的资讯。

内容

第 1 章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品类型细分的市场
  • 按组件细分的市场
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 心血管疾病患者人数增加
      • 各国政府对研发的重大投资
      • 更加註重预防/诊断保健
    • 抑制因素
      • 设备成本高
      • 缺乏熟练的技术人员
    • 影响分析

第 5 章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析
  • 定价分析

第 6 章产品类型分析

  • 1 个频道
  • 2 个频道
  • 3 个频道
  • 12 个频道
  • 其他

第 7 章（按组件）

  • 无线挂脖
  • 有线挂脖
  • Holter 分析系统/软件

第 8 章最终用户

  • 医院
  • 门诊手术中心
  • 医务室
  • 家庭医疗

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 竞争场景
  • 按产品类型进行组合比较分析
  • 市场定位/市场份额分析
  • 併购分析

第 11 章公司简介

  • ScottCare Corporation
    • 公司简介
    • 按产品类型分类的产品组合和说明
    • 主要亮点
    • 财务摘要
  • Medtronic Plc
  • GE Healthcare
  • Spacelabs Healthcare
  • FUKUDA DENSHI CO.LTD
  • Nasiff Associates, Inc
  • Biomedical Instruments Co., Ltd
  • Schiller AG
  • BTL
  • Koninklijke Philips N.V

第 12 章心臟动态心电图监测仪的全球市场-DataM

简介目录
Product Code: DMMD1453

Market Overview

Cardiac Holter Monitor Market size was valued US$ 411 million in 2021 and is estimated to reach US$ 577 million by 2029, growing at a CAGR of 5.4% during the forecast period (2022-2029).

Holter monitor is a continuous monitoring device that monitors a patient's heart for a short period (24 hours to 48 hours); some were prescribed for up to 14 days. ECG Holter monitors the first ambulatory cardiac monitor and is used for more extended period monitoring of the heart, where a resting ECG monitor cannot be used. Holter monitors have gained greater acceptance globally due to their suitable application for ambulatory services.

Market Dynamics

The global cardiac holter monitor market is growing due to the increasing need for longer period patient monitoring and reduced cost of care for ambulatory settings, rising prevalence of cardiovascular diseases is driving the growth for cardiac holter monitors in the recent years.

Rising prevalence of cardiovascular diseases drives the growth of the market

For the treatment of peripheral vascular disorders, angioplasty is advised. During this operation, the afflicted artery is examined using a cardiac catheter, which reopens the artery and flattens the blockage in the artery wall. In contrast to cancer and other chronic diseases, the American Heart Association research estimates that 92.1 million Americans were living with some type of CVD in 2020 and that CVD is the leading cause of death in the nation.

One of the main issues in developing nations worldwide is the growing senior population. Additionally, an expected period of time would see a growth in the prevalence of chronic diseases in geriatric individuals, including aortic disease, venous thromboembolism, peripheral arterial disease, etc. In 2020, more than 19.1% of the world's population of seniors aged 55 to 65 had peripheral vascular disease, with about 27% of men and more than 21% of women affected, according to a report from the Centers for Disease Control and Prevention. The largest concentration of senior citizens is in Asia and the Pacific, and their numbers are growing at an unprecedented rate.

The stringent government rules are expected to hamper the market growth

For established companies, rising price pressure from technologically improved and portable devices that are more cost-effective than standard ECG is anticipated. In addition, a decline in reimbursement rates from current government rules is expected to impact product costs. For instance, when the Medicare Physician Fee Schedule Final Rule for 2022 was published in November 2021, comprehensive external ECG monitoring was again left out of the pricing discussion. This will probably result in lower Medicare rates for gadgets, which will have an adverse effect on their uptake.

COVID-19 Impact Analysis

Due to on-hold services, such as treatment, diagnostic, and surgical services, to stop the spread of COVID-19 disease, it is projected that the COVID-19 epidemic will have a short-term negative impact on the growth of the global catheters industry. Jordan implemented a severe COVID-19-related lockout, according to the National Library of Medicine. Cardiovascular procedure volumes drastically decreased during the rigorous lockdown and gradually increased following a partial relaxation of the lockdown. However, as the government and healthcare organisations continue to enhance medical care for COVID-19 patients, catheters will be utilised more frequently in hospitals.

Industry Analysis

The global cardiac holter monitor market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The wireless holter monitors segment is expected to hold the largest market share in global cardiac holter monitor market

The wireless holter monitors are majorly incorporated in monitoring of patients suffering from palpitation, ventricular tachycardia, and atrial fibrillation. This is attributed to its large-scale utilization in large and mid-sized hospitals for the diagnosis of patients suffering from cardiovascular diseases.

Extended Holter Technology (Patch) is a long-term wearable holter device that does not require wires. It is a two-piece technology that needs data to sync to a remote device via Bluetooth technology. According to one-year data presented at the American College of Cardiology's 67th Annual Scientific Session, in Orlando, on March 19, 2018, for people at heightened risk for atrial fibrillation (AFib), wearing a self-adhering chest patch that records heart patterns may better detect the condition and facilitate more timely treatment than relying on usual care.

The study, called the mHealth Screening to Prevent Strokes (mSToPS) trial, is one of the first completely digital, nationwide, direct-to-participant and site-less clinical research programs, according to researchers. Patients consented and enrolled exclusively via a web-based platform to undergo active monitoring at home using the iRhythm Zio patch. The patch about the size of a large Band-Aid continuously records an electrocardiogram (ECG), the gold standard for detecting AFib. In line with this, manufacturers are introducing innovative and miniaturized products that offer enhanced convenience. For instance, Zio XT Patch, iRhythm, it incorporates the holter monitor into a small pedometer-sized device with an adhesive backing. A 14-day continuous cardiac rhythm monitoring with a single adhesive chest wall device can be done.

Geographical Analysis

North America region holds the largest market share in the global cardiac holter monitor market

North America was held a dominant position in the global cardiac holter monitor market in 2021. This large revenue share is mainly due to the rising prevalence of cardiovascular diseases, among other things. Rising heart related diseases and associated lifestyle diseases is driving the market for cardiac monitoring market in North America, increasing technological developments, product launches, and collaborative agreements among manufacturers are driving the growth for new product developments, which increasing product portfolio in turn enhances market opportunity. Increase in investment by various market players and the U.S. government for development and commercialization of various easy-to-use equipment is also likely to drive the market. For instance, in May 2018, Preventice Solutions launched BodyGuardian Mini, a reusable long-term and smallest Holter technology for cardiac monitoring. The new technology includes an ultra-small cardiac monitor that can measure ECG up to 14 days and can transfer data to a physician in an easy-to-read report. Hence, launch of such technologically advanced products to address the needs of physicians and patients is expected to boost market growth in the coming years.

Competitive Landscape

The cardiac holter monitor market is highly competitive, owing to big market players in the industry. The key cardiac holter monitor players which are contributing to the growth of the global market include Medtronic Plc, GE Healthcare, Spacelabs Healthcare, FUKUDA DENSHI CO.LTD., Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., Schiller AG, BTL, Koninklijke Philips N.V., ScottCare Corporation.

Global Cardiac Holter Monitor Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: The Reveal LINQ system includes a tiny insertable monitor placed just under the skin and the MyCareLink patient monitor.

The global cardiac holter monitor market report would provide an access to an approx. 45+ market data table, 40+ figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product type
  • 3.2. Market Snippet by Components
  • 3.3. Market Snippet by End-user
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the number of patients subjected to cardiovascular diseases
      • 4.1.1.2. Significant investment in research and development by the governments
      • 4.1.1.3. Rising focus on preventive and diagnostic healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. Higher costs of devices
      • 4.1.2.2. Lack of skilled technicians
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis

6. By Product type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
  • 6.3. Market Attractiveness Index, By Product type
    • 6.3.1. 1-Channel *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2021-2029
    • 6.3.2. 2-Channel
    • 6.3.3. 3-Channel
    • 6.3.4. 12-Channel
    • 6.3.5. Others

7. By Components

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
  • 7.3. Market Attractiveness Index, By Components
    • 7.3.1. Wireless Holter*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.3.2. Wired Holter
    • 7.3.3. Holter Analysis System & Software

8. By End-user

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  • 8.3. Market Attractiveness Index, By End-user
    • 8.3.1. Hospitals *
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2021-2029
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Clinics
    • 8.3.4. Homecare Settings

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Comparative Product type Portfolio Analysis
  • 10.3. Market Positioning/Share Analysis
  • 10.4. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. ScottCare Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Medtronic Plc
  • 11.3. GE Healthcare
  • 11.4. Spacelabs Healthcare
  • 11.5. FUKUDA DENSHI CO.LTD
  • 11.6. Nasiff Associates, Inc
  • 11.7. Biomedical Instruments Co., Ltd
  • 11.8. Schiller AG
  • 11.9. BTL
  • 11.10. Koninklijke Philips N.V

LIST NOT EXHAUSTIVE

12. Global Cardiac Holter Monitor Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us